• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,409.98 254.36
( 0.33%)
Global Indices
Nasdaq
51,515.27 -505.40
(-0.97%)
Dow Jones
7,441.22 -91.13
(-1.21%)
Hang Seng
71,050.31 1,148.06
(1.64%)
Nikkei 225
10,505.62 11.41
(0.11%)
Forex
USD-INR
94.55 -0.09
(-0.09%)
EUR-INR
109.66 -0.13
(-0.12%)
GBP-INR
126.84 -0.25
(-0.20%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

ERIS Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
540596
INE406M01024
230.6075957
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ERIS
76.93
19540.76
EPS(TTM)
Face Value()
Div & Yield %
18.33
1
0.51
 

Atishay standalone net profit declines 25.00% in the March 2026 quarter
Apr 25,2026
Net profit of Atishay declined 25.00% to Rs 1.77 crore in the quarter ended March 2026 as against Rs 2.36 crore during the previous quarter ended March 2025. Sales declined 20.79% to Rs 10.17 crore in the quarter ended March 2026 as against Rs 12.84 crore during the previous quarter ended March 2025.

For the full year,net profit rose 1.85% to Rs 7.14 crore in the year ended March 2026 as against Rs 7.01 crore during the previous year ended March 2025. Sales rose 9.03% to Rs 55.77 crore in the year ended March 2026 as against Rs 51.15 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales10.1712.84 -21 55.7751.15 9
OPM %26.5522.98 -17.7318.73 -
PBDT2.983.43 -13 11.7211.41 3
PBT2.343.07 -24 9.649.58 1
NP1.772.36 -25 7.147.01 2